EPISODE · Apr 26, 2025 · 14 MIN
Laminar Pharma avanza contra el cáncer
from Biotecnología Capital · host Capital Radio
Hablamos con Paula Fernández, directora científica de Laminar Pharma, de su producto más avanzado, el LAM561, que se prueba en adultos ya para el tratamiento del glioblastoma.
Embed this episode
NOW PLAYING
Laminar Pharma avanza contra el cáncer
0:00
14:56
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Biotecnología Capital?
This episode is 14 minutes long.
When was this Biotecnología Capital episode published?
This episode was published on April 26, 2025.
Can I download this Biotecnología Capital episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!